Hai Yan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Nature reviews. Clinical oncology

Acta neuropathologica communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn Gunn, Matti Myllykoski, John Z Cao, Manna Ahmed, Bofu Huang, Betty Rouaisnel, Bill H Diplas, Michael M Levitt, Ryan E Looper, John G Doench, Keith L Ligon, Harley I Kornblum, Samuel K McBrayer, Hai Yan, Cihangir Duy, Lucy A Godley, Peppi Karppinen, Julie-Aurore Losman
(R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers. Cancer discovery (2023)
Christopher J Pirozzi, Hai Yan
The implications of IDH mutations for cancer development and therapy. Nature reviews. Clinical oncology 18 (10) (2021)
Cheng Xu, Heng Liu, Christopher J Pirozzi, Lee H Chen, Paula K Greer, Bill H Diplas, Liwei Zhang, Matthew S Waitkus, Yiping He, Hai Yan
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist. Acta neuropathologica communications 9 (1) (2021)